Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual)- Panel Transcript
Welcome to our panelists, corporate and investment clients. I wish all a healthy and productive remainder of the first quarter. I'm Michael Meyers, Vice Chair, Head of M&A and Strategic Advisory Services at H.C. Wainwright. On behalf of John Chambers, our President and Head of Investment Banking; Richard Gormley, our Vice Chair and President of Capital Markets and all of our colleagues at H.C. Wainwright, it's my great pleasure to welcome you to our Global Life Sciences Conference.
This conference follows our 22nd Annual Global Investors Conference in September and our BioConnect 2021 Conference in January. And while the venues have been quite different for all of us since March of last year, we look forward to offering you a rich virtual content over the next 4 days -- 2 days, excuse me, to include our panel of this afternoon and virtual wine tour and tasting of this evening.
With that, I would now like to introduce our moderator and facilitator of our reimbursement
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |